Renaissance Technologies LLC Decreases Stake in Nutex Health Inc. (NASDAQ:NUTX)

Renaissance Technologies LLC reduced its position in Nutex Health Inc. (NASDAQ:NUTX) by 63.8% in the second quarter, HoldingsChannel.com reports. The institutional investor owned 56,903 shares of the company’s stock after selling 100,497 shares during the period. Renaissance Technologies LLC’s holdings in Nutex Health were worth $34,000 as of its most recent SEC filing.

Separately, One Plus One Wealth Management LLC raised its stake in Nutex Health by 2,017.5% during the first quarter. One Plus One Wealth Management LLC now owns 5,293,720 shares of the company’s stock worth $508,000 after acquiring an additional 5,043,720 shares during the period. 5.32% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts have commented on NUTX shares. Benchmark upped their target price on shares of Nutex Health from $30.00 to $45.00 and gave the stock a “buy” rating in a research report on Wednesday, August 21st. Maxim Group started coverage on shares of Nutex Health in a research report on Wednesday, September 18th. They issued a “buy” rating and a $45.00 target price for the company.

Insider Activity

In other news, CFO Jon Christian Bates bought 1,350 shares of the stock in a transaction that occurred on Thursday, August 22nd. The shares were acquired at an average cost of $21.46 per share, for a total transaction of $28,971.00. Following the purchase, the chief financial officer now owns 2,277 shares of the company’s stock, valued at $48,864.42. This represents a 100.00 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. 38.52% of the stock is owned by insiders.

Nutex Health Trading Down 2.5 %

Shares of NASDAQ:NUTX opened at $19.30 on Tuesday. The stock has a market capitalization of $95.96 million, a price-to-earnings ratio of -1.82 and a beta of 0.10. Nutex Health Inc. has a 1-year low of $4.16 and a 1-year high of $45.00. The company has a debt-to-equity ratio of 3.04, a quick ratio of 1.55 and a current ratio of 1.59. The company has a 50 day moving average price of $19.41 and a 200 day moving average price of $11.46.

Nutex Health (NASDAQ:NUTX) last issued its quarterly earnings results on Thursday, August 8th. The company reported ($0.07) EPS for the quarter, beating the consensus estimate of ($0.29) by $0.22. The business had revenue of $76.08 million during the quarter. Nutex Health had a negative net margin of 13.73% and a negative return on equity of 43.79%.

Nutex Health Profile

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.